SUMMARY
frequency [2] . In general, local anaesthetics lead to subjective reports of fatigue and dizziness [1] [2] [3] [4] [5] .
The magnitude and duration of such effects is likely to be of concern in the selection of anaesthetic agents, particularly in day-case patients. In the study by Korttila [1] , the mean peak plasma concentration after i.m. injection of plain lignocaine was 1.37 (j.g ml" 1 , a concentration likely to be found, at least transiently, during regional anaesthesia [6] .
It is difficult to assess the relationship between plasma concentrations and performance from this type of experiment. Only one dosage of each drug was used and the venous plasma concentration is an uncertain indicator of concentrations at the site of action when drug concentrations are changing, as occurs with single-dose studies.
An alternative is to use a continuous infusion of drug to obtain an approximate steady state [7] [8] [9] . This has several advantages. First, the arteriovenous artefact can be greatly reduced. Second, acute habituation effects may be detected. Third, a comprehensive test battery may be given with all tests being administered under similar drug conditions.
In the present experiment, subjective and objective effects of lignocaine were studied using infusions at two rates, calculated to achieve plasma concentrations of 1 and 2 ug ml" 1 , in order to span
Several studies have shown that local anaesthetics may affect psychological performance and subjective state. Thus slowing of reaction times has been observed with lignocaine [1] , while both bupivacaine and etidocaine caused an increase in reaction time, but a reduction in critical nicker the maximum concentration of 1.37 ug ml 1 obtained by Korttila [1] .
SUBJECTS AND METHODS
We studied nine healthy male volunteers aged 21-34 yr (mean 28.4 yr) and weights 66-82 kg (mean 74.3 kg). No subject was taking any medication. All subjects gave written informed consent to the study, which was approved by the Ethics Committee of the Royal Infirmary, Edinburgh.
Subjects were given three treatments in random order: placebo (saline); low dose lignocaine (target placebo concentration 1 ug ml" 1 ); high dose lignocaine (target 2 ug ml" 1 ) (table I) . At least 7 days elapsed between sessions. A short test battery was carried out at baseline and repeatedly during the infusion, while a more comprehensive battery designed to assess a broad range of CNS functions [10, 11] was performed once.
Digit-symbol substitution test. In this penciland-paper test, there was a key which matched nine symbols to the numbers 1-9. A series of random numbers was printed in a grid on the sheet and the subject wrote the corresponding symbol under each number, as quickly as possible. The numbers of correct and incorrect symbols written in 90 s were recorded [12] .
Symbol-digit substitution test. In this automated version of the above test, subjects saw a key on a monitor screen which matched the nine symbols to the digits 1-9. A series of symbols appeared in a box below the key, one at a time, and the subject responded by pressing the appropriate number key as quickly as possible. The number of Choice reaction time. This used an apparatus with a semicircular arrangement of six buttons with a light by each one. The subject initially placed his finger on a seventh button at the centre of the semicircle. At random intervals one of the lights was illuminated, and the subject responded by pressing the appropriate button as quickly as possible. The mean latency and total response time over 30 responses was recorded [13, 14] .
Critical flicker fusion threshold. The subject observed a group of four lights which flickered at an increasing frequency. The subject responded when the lights appeared to be steady. The test was repeated with the frequency decreasing, the subject responding when flicker appeared to begin. The mean frequency of three observations in each direction was taken as the threshold [13] .
Continuous attention task.
A series of geometric patterns was flashed on a monitor screen, each pattern being shown for 0.1s, the interval between patterns being 1.5-2.5 s. The subject's task was to respond whenever two consecutive patterns were the same. A total of 240 presentations, with 40 repetitions, was used on each occasion [10, 11] . The total number of errors (both false-positive and false-negative) was recorded, and the error index calculated [15] .
Block pattern recognition test.
A series of geometric patterns, as used in the continuous attention task, was displayed on a monitor screen, each followed, after a short interval-the viewing time-by a random pattern of much smaller black and white squares, which remained on the screen for Is. This second pattern acted as a backward mask, preventing further visual processing of the original stimulus. Two seconds after the onset of the original stimulus, four patterns appeared on the screen, and the subject responded by pressing a button corresponding to the stimulus pattern. Viewing times of 20-100 ms and an unmasked condition were used.
Sternberg memory scanning test. The subject was required to memorize a set of 1, 3 or 5 digits presented on the monitor screen. A series of digits was then shown on the screen, and for each digit the subject pressed a YES button if the digit was in the initial set, a NO button otherwise. The reaction times for the correct responses for each of the conditions was recorded [16] . Two presentations of series of 20 digits were made for each set size.
Inspection time. In this measure of processing speed, the subject was presented with two illuminated vertical lines, one longer than the other. This was followed by a mask, consisting of two long lines. The subject responded by pressing a left or right button corresponding to the longer line in the original display. The inspection time (the interval between onset of stimulus and onset of mask) was varied according to the PEST algorithm, an adaptive procedure which decreases viewing time when subjects perform accurately, and increases it when errors occur. A progressive decrease in the step size allows the algorithm to "home in" to the time necessary for 85 % correct recognition [17, 18] .
Visual analogue scales. Subjective effects were measured using 10 visual analogue scales, the opposite ends of which were marked: alertdrowsy; steady-dizzy; bored-interested; calmtense; well-ill; lethargic-energetic; pleasantunpleasant; normal-abnormal; sober-drunk; and clearheaded-muzzy. Non-specific questioning was also used ("How do you feel at the moment?"), and any symptom or other item reported or observed was rated by the tester on a seven-point severity scale.
Choice reaction time and critical nicker fusion were measured using the Leeds Psychomotor Tester [13] . Other automated tests were administered using a BBC Master 128 microcomputer with a separate response box [10] .
Procedures
Each subject first took part in a familiarization session in which all the tests in the battery were introduced and practised.
Subjects were instructed to abstain from alcohol during the 24 h preceding the test sessions, and from caffeine and tobacco on the days of the test sessions, until completion of all procedures.
In each of the main sessions, a cannula (18-gauge Venflon) was inserted into the antecubital fossa of the non-dominant arm, for blood sampling. A smaller cannula (21-gauge Venflon) was inserted into a vein on the dominant forearm and connected to the infusion pump with flexible nylon tubing. This was arranged to allow free movement of the arm. A tap was fitted into the cannulae behind the shoulder. The pump and connections were positioned behind the subject so that he would not be aware of the starting time of the infusions. Administration was blind to the subject and to the experimenter responsible for administering the tests. Infusion solutions were prepared by a physician who also had medical responsibility for the subjects. The physician was not blinded.
Saline was infused initially, to allow the subjects to settle and for baseline testing to be carried out. After approximately 20 min the loading dose commenced and after a further 10 min the maintenance dose was started. At termination of the main infusion (approximately 1.5 h) saline was resumed. For the low dose lignocaine condition, the loading dose was 1.26 mg kg" 1 , followed by a maintenance infusion of 13.2 ug kg" 1 min" 1 . For high dose lignocaine, double these amounts were used. For the placebo condition, all infusions comprised saline, but syringes and pump rates were changed at the same times as for the active infusions.
A short test battery, consisting of digit-symbol substitution, symbol-digit substitution, and the visual analogue scales was performed at 10-min intervals during 'the initial saline infusion and during the first 30 min of the experimental infusion. The full battery was performed at 30-80 min, followed by the short battery. The experimental infusion was replaced by saline, and the short battery performed again at 10-min intervals for 30 min. During the whole test period, non-specific questioning was carried out at approximately 10-min intervals, except when tests were in progress.
Blood samples were obtained for measurement of plasma lignocaine concentrations, before the infusion, at 30, 60 and 90 min after commencement of the main infusion, and at 15 and 30 min during the final saline infusion. Plasma concentrations of lignocaine were measured by HPLC [19] .
Statistical analysis
The main outcome measures used were the mean scores for the items in the short test battery over the active infusion period. The difference between the scores at 30 and 90 min were assessed in order to test for acute tolerance effects, and the mean scores before active infusion commenced (baseline) and the final score (at 30 min after saline recommenced) were also analysed. These 
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measures and the scores for the individual tests in the full test battery were analysed using General Linear Models applied to the ranked data set [20] to test for effects of treatment and session (order effect). Where significant treatment effects were found, pairwise comparisons were carried out. The level of significance was P < 0.05.
RESULTS
Data are presented by treatment for the full test battery in table II, and those for the short battery, including the subjective measures, in table III. Of the objective measures studied, only the digitsymbol substitution test showed statistically signif-icant treatment effects (P < 0.001). All three pairwise comparisons were significant for this measure. The low dose of lignocaine was associated with an increase in the number of correct responses (improved performance) while the high dose led to a decrease (impairment). The subjective measures (table III) showed clear effects of lignocaine. Seven of the 10 scales showed significant effects, with subjects feeling more interested (P < 0.05), drowsy (P < 0.01), dizzy, tense, abnormal, drunk and muzzy (P < 0.001). In most subjects these changes were clearly dose-related, with the effect of the low dose intermediate between that of the high dose and placebo.
No measure showed significant change between the 30-min and 90-min time points, and there were no differences between sessions at baseline. No statistically significant treatment effects were apparent 30 min after the end of the active infusion. Significant order effects were evident for pattern recognition (median (%) correct at 100 ms: session 1, 50; session 2, 52; session 3, 58); for the sober-drunk visual analogue scale (median position (mm): session 1, 9; session 2, 15; session 3, 33; the larger numbers indicate increasing feelings of drunkenness); and for the normal-abnormal visual analogue scale (median position (mm): session 1, 19; session 2, 19; session 3, 48; the larger numbers indicate increasing feelings of abnormality). The time course of the effect of lignocaine is shown in figure 1 . The effects on digit-symbol substitution and abnormal feelings appeared to peak during the loading dose, while drowsiness was more constant during the active infusion period.
Lignocaine was clearly associated with somnolence (tired, drowsy or sleepy), and there were more reports of paraesthesia, tinnitus, dizziness, taste in mouth and muzziness with lignocaine than with placebo (table IV) .
Mean plasma concentrations of lignocaine over the three time points were in the range 0.75-1.16 ug ml' 1 for the low dose session (mean 
DISCUSSION
These results are in general agreement with the previous findings of Korttila [1] , notably that lignocaine affected performance at concentrations likely to be found in clinical use. However, the effect was confined to a single objective test measure, the digit-symbol substitution test. The most striking finding was that with the smaller dose of lignocaine used there was a significant improvement in performance on this test, while with the greater dose, impairment occurred. Although a substantial number of statistical tests were performed in the present study, this is unlikely to be a chance finding for two reasons. First, the summary measures from the short battery were identified as primary measures in advance of the analysis. Second, the level of significance was such that, even if correction for multiplicity were considered appropriate, a significant result would still be found.
It is of interest that digit-symbol substitution showed effects of lignocaine, while the similar symbol-digit task was not affected significantly. The most obvious difference between the two tasks is that the latter is automated, but another aspect is pacing. The pencil-and-paper digitsymbol task is paced by the subject, while the automatic symbol-digit task is paced automatically by the computer. Moreover, there is no possibility of the subject looking ahead in the latter task. These factors may substantially alter the nature of the task [21] .
The mechanism of the biphasic response is unclear. Several studies have suggested that performance improvements may occur with small doses of CNS depressants such as benzodiazepines [22] . These results are usually interpreted in terms of anxiolytic or relaxant effects. Such effects seem unlikely here, in view of the dose-related increase in tension seen with the visual analogue scales.
Korttila's results for plain lignocaine showed only impairments, again only with a single measure (cumulative reaction time test). However, with other local anaesthetics, improvements occurred in some measures [2] , but no effects in others [23] . As all these studies used single doses of local anaesthetics, it is not clear if these findings indicate differences between drugs, or if they are the result of assessing different parts of basically similar dose-response curves.
In contrast with the objective effects of lignocaine, subjective effects were apparent on a broad range of measures, with an obvious dose-response relationship. Subjects clearly felt the effects of both doses of the drug, the greatest effects being on the normal-abnormal and clearheadedmuzzy scales. There was no significant effect on the pleasant-unpleasant scale, although there was a slight trend towards the unpleasant end. Although the effect on the alert-idrowsy scale was less marked than on abnormal or muzzy feelings, there was a clear indication of drowsiness, and this was apparent also from non-specific questioning.
The occurrence of order effects with objective measures is likely to reflect the effects of practice on task performance. Thus the improvement in performance with pattern recognition tasks suggests that the initial practice session may have been inadequate. The statistical method used is valid in the presence of order effects, but some loss of power may occur. Practice appears to have been sufficient for the other measures.
Several of the measures, for example digitsymbol substitution and normal-abnormal VAS, show a peak effect 10-20 min after commencement of the infusion, with the effect decreasing rapidly (although not returning to placebo levels). This is most likely to be caused by a peak of lignocaine concentration during loading, although rapid habituation cannot be excluded. However, the latter explanation is made less likely by the fact that no significant difference was seen for any measure between 30 and 90 min.
The steady state phase of this experiment should resemble conditions during recovery from the effects of local anaesthetics. There is evidence for impairment at a plasma concentration of lignocaine around 1.5-2 \ig mg" 1 , but not at half this concentration. Thus it would seem unlikely that concentrations of 1 ug mg" 1 or less would be associated with significant impairment. Moreover, the fact that the subjective effects were clearly evident at smaller concentrations than caused impairment, suggests that simply questioning patients should be a useful index of recovery. These hypotheses, however, need to be tested in patients recovering from such procedures and, preferably, compared with recovery from the effects of general anaesthetics.
